METHOD
Seventy cows from one commercial farm in the Waikato region of New Zealand received one of seven dose rates (0, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5 g/100 kg bodyweight (BW)) of ZnO given by oral drench, every morning, for 7 consecutive days. Every afternoon, milk and blood samples were collected from all cows. Free-catch faecal samples were collected during the afternoon milking on 3 days throughout the trial.Linear mixed models were used to assess the relationship between the concentration of Zn in serum and that in milk, and in faeces, respectively, and the relationship between dose rate of ZnO and concentrations of Zn in serum, faeces and milk, respectively. Receiver operating characteristic curve analysis was used to determine the ability of the Zn concentration in serum, milk and faeces to predict that a cow had been treated with a dose of ZnO ≥2.5 g/100 kg, the industry-recommended dose rate needed to protect against facial eczema.Results: A 1-µmol/L increase in Zn concentration in milk was associated with a 0.14 (95% CI=0.11-0.17) µmol/L increase in Zn concentration in serum. Zn concentration in faeces was scaled by its SD; a 1 SD increase was associated with a 1.83 (95% CI=0.54-3.12) µmol/L increase in zinc concentration in serum. Zn concentrations in serum and faeces increased with increasing dose rates of ZnO. No differences in Zn concentrations in milk were noted between animals dosed with 1.5-3.5 g ZnO/100 kg BW, inclusive. At the optimal threshold for Zn concentration in serum, 22 µmol/L, the sensitivity was 0.76 (95% CI=0.69-0.82) and specificity 0.85 (95% CI=0.80-0.89). For the concentration of Zn in faeces, the optimal threshold was defined as 17.36 mmol/kg, with a corresponding sensitivity of 0.84 (95% CI=0.84-0.85) and specificity of 0.85 (95% CI=0.73-0.94). At the optimal threshold for the Zn concentration in milk (76.6 µmol/L), the sensitivity was lower than the other two sample types at 0.59 (95% CI=0.52-0.67), but with a similar specificity of 0.84 (95% CI=0.79-0.88).Conclusions and clinical relevance: The concentration of Zn in milk shows promise as an initial screening test to identify dairy farms that do not provide adequate zinc to provide protection against FE.
[1]
E. Cuttance,et al.
Variability in concentrations of zinc in serum and feed when using zinc oxide as a supplement for the prevention of facial eczema
,
2016,
New Zealand veterinary journal.
[2]
E. Cuttance,et al.
Facial eczema management protocols used on dairy farms in the North Island of New Zealand and associated concentrations of zinc in serum
,
2016,
New Zealand veterinary journal.
[3]
J. Parkins,et al.
The effect of zinc oxide and elemental zinc boluses on the concentrations of Zn in serum and faeces, and on providing protection from natural Pithomyces chartarum challenge in calves
,
2010,
New Zealand veterinary journal.
[4]
C. Miles,et al.
A history of facial eczema (pithomycotoxicosis) research
,
2009
.
[5]
C. Dawson,et al.
Failure of zinc supplementation to prevent severe facial eczema in cattle fed excess copper
,
2007,
New Zealand veterinary journal.
[6]
R. Munday,et al.
A zinc-containing intraruminal device for prevention of the sporidesmin-induced cholangiopathy of facial eczema in calves
,
2001,
New Zealand veterinary journal.
[7]
R. Munday.
Studies on the mechanism of toxicity of the mycotoxin sporidesmin 3—inhibition by metals of the generation of superoxide radical by sporidesmin
,
1984,
Journal of applied toxicology : JAT.
[8]
B. Smith,et al.
The protective effect of zinc sulphate in experimental sporidesmin intoxication of lactating dairy cows.
,
1978,
New Zealand veterinary journal.
[9]
W. J. Miller,et al.
INFLUENCE OF HIGH LEVELS OF DIETARY ZINC ON ZINC IN MILK, PERFORMANCE AND BIOCHEMISTRY OF LACTATING COWS.
,
1965,
Journal of dairy science.
[10]
P. Brook.
Ecology of the fungus Pithomyces chartarum (Berk. & Curt.) M. B. Ellis in pasture in relation to facial eczema disease of sheep
,
1963
.